Nadav Kidron - Apr 17, 2023 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
President and CEO, Director
Signature
/s/ Nadav Kidron
Stock symbol
ORMP
Transactions as of
Apr 17, 2023
Transactions value $
$0
Form type
4
Date filed
4/20/2023, 06:00 AM
Previous filing
Mar 16, 2023
Next filing
May 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +279K +26.49% 1.33M Apr 17, 2023 Direct F1
holding ORMP Common Stock 126K Apr 17, 2023 By wholly-owned corporation
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 23,250 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.